Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dacal

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Respiratory Disease|October 20, 2018
Asthma-COPD overlap: identification and optimal treatmentBorja G Cosío, David Dacal, Luis Pérez de Llano
Journal of Asthma and Allergy|March 19, 2021
Phenotype-Guided Asthma Therapy: An Alternative Approach to GuidelinesLuis Pérez de Llano, David Dacal Rivas, Nagore Blanco Cid, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 5, 2026
Biologics Use in Eosinophilic Lung Disease: Controversies and ConsensusLuis Pérez de Llano, David Dacal Rivas, Ian Pavord, et al.
Medicina Clinica|July 12, 2020
[Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors]Rafael Golpe, Luis A Pérez-de-Llano, David Dacal, et al.
Respiratory Medicine and Research|August 27, 2024
Diabetes mellitus with poor glycemic control is a risk factor for pneumonia in COPDRafael Golpe, Juan-Marco Figueira-Gonçalves, Laura Arias-Zas, et al.
Medicina Clinica (English Ed.)|February 1, 2021
Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitorsRafael Golpe, Luis A Pérez-de-Llano, David Dacal, et al.
Respiratory Medicine and Research|December 26, 2021
A new, three-dimensional approach to the GOLD COPD assessment toolRafael Golpe, Juan Marco Figueira-GonÇalves, Carlos A Amado, et al.
Lung|September 6, 2022
Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality RiskRafael Golpe, Juan Marco Figueira-Gonçalves, Carlos Antonio Amado-Diago, et al.
Annals of Thoracic Medicine|November 17, 2022
Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobaccoRafael Golpe, Nagore Blanco-Cid, David Dacal-Rivas, et al.
Journal of Investigational Allergology & Clinical Immunology|May 5, 2026
A Retrospective Multicenter Cohort Study on the Effectiveness of Triple Inhaled Therapy in Severe AsthmaDavid Dacal Rivas, Nagore Blanco Cid, Daniel Pérez Ortiz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Respiratory Disease|October 20, 2018
Asthma-COPD overlap: identification and optimal treatmentBorja G Cosío, David Dacal, Luis Pérez de Llano
Journal of Asthma and Allergy|March 19, 2021
Phenotype-Guided Asthma Therapy: An Alternative Approach to GuidelinesLuis Pérez de Llano, David Dacal Rivas, Nagore Blanco Cid, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 5, 2026
Biologics Use in Eosinophilic Lung Disease: Controversies and ConsensusLuis Pérez de Llano, David Dacal Rivas, Ian Pavord, et al.
Medicina Clinica|July 12, 2020
[Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors]Rafael Golpe, Luis A Pérez-de-Llano, David Dacal, et al.
Respiratory Medicine and Research|August 27, 2024
Diabetes mellitus with poor glycemic control is a risk factor for pneumonia in COPDRafael Golpe, Juan-Marco Figueira-Gonçalves, Laura Arias-Zas, et al.
Medicina Clinica (English Ed.)|February 1, 2021
Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitorsRafael Golpe, Luis A Pérez-de-Llano, David Dacal, et al.
Respiratory Medicine and Research|December 26, 2021
A new, three-dimensional approach to the GOLD COPD assessment toolRafael Golpe, Juan Marco Figueira-GonÇalves, Carlos A Amado, et al.
Lung|September 6, 2022
Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality RiskRafael Golpe, Juan Marco Figueira-Gonçalves, Carlos Antonio Amado-Diago, et al.
Annals of Thoracic Medicine|November 17, 2022
Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobaccoRafael Golpe, Nagore Blanco-Cid, David Dacal-Rivas, et al.
Journal of Investigational Allergology & Clinical Immunology|May 5, 2026
A Retrospective Multicenter Cohort Study on the Effectiveness of Triple Inhaled Therapy in Severe AsthmaDavid Dacal Rivas, Nagore Blanco Cid, Daniel Pérez Ortiz, et al.
Pageof 2